February 09, 2018
Consumers suing Otsuka America Pharmaceutical Inc. over side effects of its antipsychotic drug Abilify asked a Florida federal judge Thursday to sanction the drugmaker for allegedly destroying important pre-2007 communications, saying Otsuka waited too long to disclose the lack of evidence it argues is crucial to its case.